Free CME from PeerView


Surgery CME

Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhibitor–Related Bleeding
Truman J. Milling Jr., MD, FACEP / W. Frank Peacock, MD, FACEP, FACC, FESC
October 09, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond
Milind Desai, MD, MBA / Anjali Tiku Owens, MD
October 08, 2023
Credits: 0.75 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: Leveraging Science, Enhancing Collaboration, and Improving Outcomes With Neoadjuvant and/or Adjuvant Checkpoint Inhibition
Jessica Donington, MD
September 23, 2023
Shmuel Shoham, MD/Ghady Haidar, MD
Credits: 1.0 CME / AAPA
PVI, PeerView Institute for Medical Education
What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and Efficacy
Shmuel Shoham, MD / Ghady Haidar, MD
June 06, 2023
Credits: 1.0 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Taking the Targeted Option for Myelofibrosis: Insights on Modern JAKi Platforms & Emerging Therapeutics
Ruben A. Mesa, MD, FACP
June 04, 2023
Credits: 1.5 CME / MOC / AAPA
PVI, PeerView Institute for Medical Education
Building on the Immunotherapy Foundation for Head and Neck Cancer: Lessons Learned, Practical Guidance, and Next Steps in Care
Barbara Burtness, MD
June 02, 2023
Credits: 0.5 CME
Medical Learning Institute, Inc.
Visualizing Progress in the Treatment of Chronic Active Antibody-Mediated Rejection: A Closer Look at the Clinical Potential of Targeting IL-6 to Improve Outcomes in the Kidney Transplant Setting
Stanley C. Jordan, MD, FASN, FAST
May 11, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immunotherapy, Individualize Treatment Plans, and Improve Cure Rates in Resectable NSCLC
Jonathan D. Spicer, MD, PhD, FRCSC
May 06, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
Laura S. Dominici, MD, FACS
March 24, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
Stephanie Lee, MD, MPH
March 22, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
Jennifer Wargo, MD, MMSc
March 22, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
The Time Is Now for Outpatient CAR-T: Essential Infrastructure, Lessons From Transplant, and New Evidence
Olalekan Oluwole, MBBS, MD
March 16, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Shaping Modern Management of Myelofibrosis: Guidance on the Conjunction of Targeted Therapy and AlloHCT
Aaron T. Gerds, MD, MS / John Mascarenhas, MD
March 16, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies: Practical Strategies for Biomarker Testing and Pathologic Response Assessment
Tricia Cottrell, MD, MPH / Lynette M. Sholl, MD
March 14, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
New Rules for VOD/SOS: Modern Risk Assessment, Diagnostic Principles, and Innovative Treatment
Prof. Mohamad Mohty / Christine N. Duncan, MD
March 13, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Addressing Key Questions About the Latest Diagnostic and Therapeutic Advances in Desmoid Tumors
Ravin Ratan, MD, M.Ed
February 23, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options
Thomas G. Martin, III, MD / Krina Patel, MD, MSc
February 15, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances
Nasser Altorki, MD / Jonathan D. Spicer, MD, PhD, FRCSC
January 21, 2023
Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 16, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
Maintaining “Intensity” for Better Outcomes in AML: Guidance on Modern, Intensive Upfront Platforms in Challenging Patient Populations
Gail J. Roboz, MD
December 09, 2022
Credits: 2.0 CME / MOC
PVI, PeerView Institute for Medical Education
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
Erika Hamilton, MD
December 07, 2022
PVI, PeerView Institute for Medical Education
On the Cusp of Change: Modernizing the Treatment of Desmoid Tumors With Novel Gamma Secretase Inhibitors
Bernd Kasper, MD, PhD
November 30, 2022
Johns Hopkins University School of Medicine
Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge
Shmuel Shoham, MD
July 08, 2022
PVI, PeerView Institute for Medical Education
Navigating the Shifting Treatment Paradigm in ER+/HER2- Breast Cancer: Harnessing Modern Treatment Options and the Expanding Evidence Base to Better Patient Care and Outcomes in Early and Advanced Disease
Aditya Bardia, MD, MPH
June 16, 2022
PVI, PeerView Institute for Medical Education
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care
Robert I. Haddad, MD
June 05, 2022
The Medical College of Wisconsin
The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
Jeanne M. Palmer, MD
May 27, 2022
The Medical College of Wisconsin
CAR-T Cell Therapy: Are You Up to the Challenge? New Evidence and Best Practices Driving Modern Cellular Therapies as a Standard of Care for Leukemia and Lymphoma
Michael R. Bishop, MD
May 25, 2022
The Medical College of Wisconsin
Upgrading the VOD/SOS Management Tool Kit: Guidance for Effective Diagnostic Confirmation, Grading, and Treatment
Nelson Chao, MD, MBA
April 26, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 10, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView